Unraveling A Complex Genetic Disease: Age-related Macular Degeneration

Survey of Ophthalmology

Volumn 51, Issue 6, 2006, Pages 576-586

  Chamberlain, Matt ^a   Baird, Paul ^a,b   Dirani, Mohamed ^a,b   Guymer, Robyn ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VISION COOPERATIVE RESEARCH CENTRE   (Australia)

Author keywords

age related macular degeneration; environment; genetic epidemiology; genetic polymorphism; genetic techniques; phenotype; variation (genetics)

Indexed keywords

ABC TRANSPORTER A1; ARYLDIALKYLPHOSPHATASE 1; COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE; FIBULIN; FIBULIN 6; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH; RETINA MACULA AGE RELATED DEGENERATION;

EPIDEMIOLOGY, MOLECULAR; HUMANS; MACULAR DEGENERATION; PHENOTYPE; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 33750497434     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2006.08.003     Document Type: Article

References (106)

1. ___: The International HapMap Project. Nature 426 (2003) 789-796
2. Abecasis G.R., Yashar B.M., Zhao Y., et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 74 (2004) 482-494
3. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67 (2000) 487-491
4. Allikmets R., Shroyer N.F., Singh N., et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277 (1997) 1805-1807
5. Allikmets R., Singh N., Sun H., et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15 (1997) 236-246
6. Alpert J.S. The Vioxx debacle. Am J Med 118 (2005) 203-204
7. Altmüller J., Palmer L.J., Fischer G., et al. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 69 (2001) 936-950
8. Assink J.J., Klaver C.C., Houwing-Duistermaat J.J., et al. Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. Ophthalmology 112 (2005) 482-487
9. Baird P.N., Guida E., Chu D.T., et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (2004) 1311-1315
10. Bird A.C. The Bowman lecture. Towards an understanding of age-related macular disease. Eye 17 (2003) 457-466
11. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995) 367-374
12. Blom A.M., Kask L., Ramesh B., et al. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch Biochem Biophys 418 (2003) 108-118
13. Botstein D., and Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33 Suppl (2003) 228-237
14. Cardon L.R., and Abecasis G.R. Using haplotype blocks to map human complex trait loci. Trends Genet 19 (2003) 135-140
15. Cideciyan A.V., Aleman T.S., Swider M., et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 13 (2004) 525-534
16. Cooper R.S. Gene-environment interactions and the etiology of common complex disease. Ann Intern Med 139 (2003) 437-440
17. Daly M.J., Rioux J.D., Schaffner S.F., et al. High-resolution haplotype structure in the human genome. Nat Genet 29 (2001) 229-232
18. De La Paz M.A., Guy V.K., Abou-Donia S., et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 106 (1999) 1531-1536
19. DeAngelis M.M., Lane A.M., Shah C.P., et al. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 122 (2004) 575-580
20. Edwards A.O., Ritter R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
21. Edwards B.J., Haynes C., Levenstien M.A., et al. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet 6 (2005) 18
22. Esparza-Gordillo J., Soria J.M., Buil A., et al. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics 56 (2004) 77-82
23. Evans J.P., Skrzynia C., and Burke W. The complexities of predictive genetic testing. BMJ 322 (2001) 1052-1056
24. Fisher S.A., Abecasis G.R., Yashar B.M., et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14 (2005) 2257-2264
25. Goldstein A.M., Falk R.T., Korczak J.F., et al. Detecting gene-environment interactions using a case-control design. Genet Epidemiol 14 (1997) 1085-1089
26. Gregory C.Y., Evans K., Wijesuriya S.D., et al. The gene responsible for autosomal dominant Doyne's honeycomb retinal dystrophy (DHRD) maps to chromosome 2p16. Hum Mol Genet 5 (1996) 1055-1059
27. Grizzard S.W., Arnett D., and Haag S.L. Twin study of age-related macular degeneration. Ophthalmic Epidemiol 10 (2003) 315-322
28. Guymer R.H., Chiu A.W., Lim L., et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?. Surv Ophthalmol 50 (2005) 194-206
29. Guymer R.H., Héon E., Lotery A.J., et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 119 (2001) 745-751
30. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102 (2005) 7227-7232
31. Hageman G.S., Luthert P.J., Victor Chong N.H., et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20 (2001) 705-732
32. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
33. Hamdi H.K., Reznik J., Castellon R., et al. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun 295 (2002) 668-672
34. Hammond C.J., Webster A.R., Snieder H., et al. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 109 (2002) 730-736
35. Hayashi M., Merriam J.E., Klaver C.C., et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 25 (2004) 111-119
36. Héon E., Piguet B., Munier F., et al. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. Arch Ophthalmol 114 (1996) 193-198
37. Hirschhorn J.N. Genetic approaches to studying common diseases and complex traits. Pediatr Res 57 (2005) 74R-77R
38. Hopper J.L. The epidemiology of genetic epidemiology. Acta Genet Med Gemellol (Roma) 41 (1992) 261-273
39. Ikeda T., Obayashi H., Hasegawa G., et al. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 132 (2001) 191-195
40. Iyengar S.K., Song D., Klein B.E., et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74 (2004) 20-39
41. Jakobsdottir J., Conley Y.P., Weeks D.E., et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77 (2005) 389-407
42. Kalayoglu M.V., Galvan C., Mahdi O.S., et al. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 121 (2003) 478-482
43. Kang S.J., Gordon D., Finch S.J., et al. What SNP genotyping errors are most costly for genetic association studies?. Genet Epidemiol 26 (2004) 132-141
44. Kenealy S.J., Schmidt S., Agarwal A., et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis 10 (2004) 57-61
45. Khoury M.J., Davis R., Gwinn M., et al. Do we need genomic research for the prevention of common diseases with environmental causes?. Am J Epidemiol 161 (2005) 799-805
46. Kimura K., Isashiki Y., Sonoda S., et al. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130 (2000) 769-773
47. Klaver C.C., Kliffen M., van Duijn C.M., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63 (1998) 200-206
48. Klaver C.C., Wolfs R.C., Assink J.J., et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116 (1998) 1646-1651
49. Klein B.E., Klein R., Lee K.E., et al. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. Am J Epidemiol 154 (2001) 207-211
50. Klein M.L., Mauldin W.M., and Stoumbos V.D. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 112 (1994) 932-937
51. Klein M.L., Schultz D.W., Edwards A., et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116 (1998) 1082-1088
52. Klein R., Klein B.E., and Moss S.E. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 147 (1998) 103-110
53. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
54. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
55. Lander E.S. The new genomics: global views of biology. Science 274 (1996) 536-539
56. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
57. Mahley R.W., and Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1 (2000) 507-537
58. Mahlknecht U., and Voelter-Mahlknecht S. Pharmacogenomics: questions and concerns. Curr Med Res Opin 21 (2005) 1041-1047
59. Majewski J., Schultz D.W., Weleber R.G., et al. Age-related macular degeneration-a genome scan in extended families. Am J Hum Genet 73 (2003) 540-550
60. Marquardt A., Stöhr H., Passmore L.A., et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet 7 (1998) 1517-1525
61. McGeer P.L., and McGeer E.G. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035 (2004) 104-116
62. McGeer P.L., and Sibley J. Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol Aging 26 (2005) 1199-1203
63. Meyers S.M., Greene T., and Gutman F.A. A twin study of age-related macular degeneration. Am J Ophthalmol 120 (1995) 757-766
64. Mitchell P., Smith W., Attebo K., et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
65. Ordovas J.M., Lopez-Miranda J., Perez-Jimenez F., et al. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis 113 (1995) 157-166
66. Penfold P.L., Madigan M.C., Gillies M.C., et al. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 20 (2001) 385-414
67. Postel E.A., Agarwal A., Schmidt S., et al. Comparing age-related macular degeneration phenotype in probands from singleton and multiplex families. Am J Ophthalmol 139 (2005) 820-825
68. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 69 (2001) 124-137
69. Radu R.A., Mata N.L., Nusinowitz S., et al. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci USA 100 (2003) 4742-4747
70. Risch N. 2004 Curt Stern Award Address. The SNP endgame: a multidisciplinary approach. Am J Hum Genet 76 (2005) 221-226
71. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
72. Rivera A., Fisher S.A., Fritsche L.G., et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration contributing independently from complement factor H to disease risk. Hum Mol Genet 14 (2005) 3227-3236
73. Rivera A., White K., Stöhr H., et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 67 (2000) 800-813
74. Robman L., Mahdi O., McCarty C., et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. Am J Epidemiol 161 (2005) 1013-1019
75. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
76. Rothman N., Garcia-Closas M., Stewart W.T., et al. The impact of misclassification in case-control studies of gene-environment interactions. IARC Sci Publ (1999) 89-96
77. Sachidanandam R., Weissman D., Schmidt S.C., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409 (2001) 928-933
78. Schick J.H., Iyengar S.K., Klein B.E., et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet 72 (2003) 1412-1424
79. Schmidt S., Klaver C., Saunders A., et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23 (2002) 209-223
80. Schmidt S., Scott W.K., Postel E.A., et al. Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12. BMC Genet 5 (2004) 18
81. Schork N.J. Genetics of complex disease: approaches, problems, and solutions. Am J Respir Crit Care Med 156 (1997) S103-S109
82. Schultz D.W., Klein M.L., Humpert A.J., et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12 (2003) 3315-3323
83. Seddon J.M., Ajani U.A., and Mitchell B.D. Familial aggregation of age-related maculopathy. Am J Ophthalmol 123 (1997) 199-206
84. Seddon J.M., Cote J., Page W.F., et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123 (2005) 321-327
85. Seddon J.M., Santangelo S.L., Book K., et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73 (2003) 780-790
86. Sing C.F., Haviland M.B., and Reilly S.L. Genetic architecture of common multifactorial diseases. Ciba Found Symp 197 (1996) 211-229 discussion 229-32
87. Smith W., and Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust NZ J Ophthalmol 26 (1998) 203-206
88. Smith W., Mitchell P., and Leeder S.R. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1518-1523
89. Souied E.H., Benlian P., Amouyel P., et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125 (1998) 353-359
90. Souied E.H., Ducroq D., Rozet J.M., et al. ABCR gene analysis in familial exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) 244-247
91. Stone E.M., Lotery A.J., Munier F.L., et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22 (1999) 199-202
92. Tomany S.C., Wang J.J., Van Leeuwen R., et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
93. Traboulsi E.I. The challenges and surprises of studying the genetics of age-related macular degeneration. Am J Ophthalmol 139 (2005) 908-911
94. Trieschmann M., Spital G., Lommatzsch A., et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 241 (2003) 1006-1012
95. VanNewkirk M.R., Nanjan M.B., Wang J.J., et al. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107 (2000) 1593-1600
96. Wang D.G., Fan J.B., Siao C.J., et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280 (1998) 1077-1082
97. Wang J.J., Mitchell P., Smith W., et al. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 10 (2003) 37-48
98. Weber B.H., Vogt G., Pruett R.C., et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8 (1994) 352-356
99. Weeks D.E., Conley Y.P., Tsai H.J., et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75 (2004) 174-189
100. Weeks D.E., Conley Y.P., Tsai H.J., et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol 132 (2001) 682-692
101. Weeks D.E., and Lathrop G.M. Polygenic disease: methods for mapping complex disease traits. Trends Genet 11 (1995) 513-519
102. Weiss K.M., and Terwilliger J.D. How many diseases does it take to map a gene with SNPs?. Nat Genet 26 (2000) 151-157
103. Yang Q., Khoury M.J., Friedman J., et al. How many genes underlie the occurrence of common complex diseases in the population?. Int J Epidemiol 34 (2005) 1129-1137
104. Zareparsi S., Branham K.E., Li M., et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77 (2005) 149-153
105. Zareparsi S., Reddick A.C., Branham K.E., et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 45 (2004) 1306-1310
106. Zurdel J., Finckh U., Menzer G., et al. CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol 86 (2002) 214-219